000 01197 a2200361 4500
005 20250517113933.0
008 ####s 0 0 eng d
022 _a1097-0142
024 7 _a10.1002/cncr.30286
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aMakker, Vicky
245 0 0 _aA multicenter, single-arm, open-label, phase 2 study of apitolisib (GDC-0980) for the treatment of recurrent or persistent endometrial carcinoma (MAGGIE study).
_h[electronic resource]
260 _bCancer
_cNov 2016
300 _a3519-3528 p.
_bdigital
500 _aPublication Type: Journal Article
700 1 _aRecio, Fernando O
700 1 _aMa, Ling
700 1 _aMatulonis, Ursula A
700 1 _aLauchle, Jennifer O
700 1 _aParmar, Hema
700 1 _aGilbert, Houston N
700 1 _aWare, Joseph A
700 1 _aZhu, Rui
700 1 _aLu, Shan
700 1 _aHuw, Ling-Yuh
700 1 _aWang, Yulei
700 1 _aKoeppen, Hartmut
700 1 _aSpoerke, Jill M
700 1 _aLackner, Mark R
700 1 _aAghajanian, Carol A
773 0 _tCancer
_gvol. 122
_gno. 22
_gp. 3519-3528
856 4 0 _uhttps://doi.org/10.1002/cncr.30286
_zAvailable from publisher's website
999 _c26396881
_d26396881